MedPath

Evaluation of withdrawing growth hormone treatment in mid-puberty in stead of at final height in a group of growth hormone deficient adolescents

Recruiting
Conditions
growth hormone deficiency<br />growth hormone treatment<br />cost-efficiency
Registration Number
NL-OMON26765
Lead Sponsor
VU medisch centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

idopathic isolated growth hormone deficiency

GH peak at diagnosis > 5 mU/L and < 30 mU/L

Exclusion Criteria

Medical condition or medication influencing growth

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Adult height (AH) minus target height (TH) SDS.
Secondary Outcome Measures
NameTimeMethod
Adult height SDS, total pubertal growth (cm), and satisfaction with attained adult height.
© Copyright 2025. All Rights Reserved by MedPath